Answers are grounded in this paper and cite their sources.
CD19 CAR T cell therapy induces complete remissions in 88% of 16 adult patients with relapsed or refractory acute lymphoblastic leukemia.
No takes yet. Share an insight, caveat, or question.
Davila et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: